Expanded haemodialysis: from operational mechanism to clinical results
- PMID: 30281134
- PMCID: PMC6168809
- DOI: 10.1093/ndt/gfy202
Expanded haemodialysis: from operational mechanism to clinical results
Abstract
Recent advances in chemical composition and new production techniques resulted in improved biocompatibility and permeability of dialysis membranes. Among these, the creation of a new class of membranes called medium cut-off (MCO) represents an important step towards improvement of clinical outcomes. Such membranes have been developed to improve the clearance of medium to high molecular weight (MW) solutes (i.e. uraemic toxins in the range of 5-50 kDa). MCO membranes have peculiar retention onset and cut-off characteristics. Due to a modified sieving profile, MCO membranes have also been described as high-retention onset. The significant internal filtration achieved in MCO haemodialysers provides a remarkable convective clearance of medium to high MW solutes. The marginal loss of albumin observed in MCO membranes compared with high cut-off membranes is considered acceptable, if not beneficial, producing a certain clearance of protein-bound solutes. The application of MCO membranes in a classic dialysis modality characterizes a new technique called expanded haemodialysis. This therapy does not need specific software or dedicated hardware, making its application possible in every setting where the quality of dialysis fluid meets current standards.
Figures
References
-
- Vanholder R, De Smet R, Glorieux G. et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934–1943 - PubMed
-
- Neirynck N, Vanholder R, Schepers E. et al. An update on uremic toxins. Int Urol Nephrol 2013; 45: 139–150 - PubMed
-
- Miyata T, Jadoul M, Kurokawa K. et al. Beta-2 microglobulin in renal disease. J Am Soc Nephrol 1998; 9: 1723–1735 - PubMed
-
- Cianciolo G, Coli L, La Manna G. et al. Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach. Int J Artif Organs 2007; 30: 864–878 - PubMed
